| 2012 | | C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome | 이관우 |
| 1999 | | Cardiovascular Effects of Prostaglandin F_(2)α Injection to the Myometrium during Cesarean Section | 이영주 |
| 2023 | | Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus | 김혜진 |
| 2018 | | Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial | 박래웅, 윤덕용, 이성준, 이진수, 최문희, 홍지만 |
| 2016 | | Characterizing treatment pathways at scale using the OHDSI network | 박래웅 |
| 2009 | | Clinical Characteristics According to the Presence of the Metabolic Syndrome in Type 2 Diabetic Patients with Hypertension | 김대중, 김태호 |
| 2011 | | Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer's disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. | 문소영, 홍창형 |
| 2004 | | Clinical Characteristics of Aneurysm Rupture with the Focus of Hypertension and Smoking as Predisposing Factors | 신용삼, 안영환, 조경기, 조기홍 |
| 2019 | | Clinical Factors Associated with Obstructive Coronary Artery Disease in Patients with Out-of-Hospital Cardiac Arrest: Data from the Korean Cardiac Arrest Research Consortium (KoCARC) Registry | 민영기, 박은정 |
| 2011 | | Clinical Manifestation of Ambulatory Blood Pressure Monitoring in Children and Adolescent with Hypertension | 이명수 |
| 2012 | | Clinical Manifestation of Ambulatory Blood Pressure Monitoring in Children and Adolescent with Hypertension | 임윤주, 정조원 |
| 2021 | | Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | 임홍석 |
| 2023 | | Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis | 최창영 |
| 2016 | | Community based strategies and directions for the management of hypertension and diabetes | 이순영 |
| 2024 | | Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study | 박래웅, 손상준 |
| 2018 | | Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study | 황교승 |
| 2006 | | Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial. | 윤명호 |
| 2020 | | Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts | 박래웅, 이성원 |
| 2017 | | Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study | 신준한 |
| 2017 | | Comparison of Optimal Diagnostic Thresholds of Hypertension With Home Blood Pressure Monitoring and 24-Hour Ambulatory Blood Pressure Monitoring | 박진선 |
| 2023 | | Comparison of the effects of dexmedetomidine and propofol on the cardiovascular autonomic nervous system during spinal anesthesia: preliminary randomized controlled observational study | 이인경, 조한범, 채윤정 |
| 2012 | | Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study | 윤명호 |
| 2016 | | Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study | 탁승제 |
| 2021 | | Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study | 박래웅 |
| 2020 | | Consideration of body mass index (BMI) in the association between hand grip strength and hypertension: Korean Longitudinal Study of Ageing (KLoSA) | 신재용 |
| 2011 | | Detection of masked hypertension and the 'mask effect' in patients with well-controlled office blood pressure. | 신준한 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status | 김대중, 하경화 |
| 2021 | | Diabetes fact sheets in Korea, 2020: An appraisal of current status | 한승진 |
| 2014 | | Direct medical costs of hypertension and associated co-morbidities in South Korea. | 민경복 |
| 2021 | | Distribution of waist-to-height ratio and cardiometabolic risk in children and adolescents: a population-based study | 심영석 |
| 2005 | | Does long-term lactation protect premenopausal women against hypertension risk? A Korean women's cohort study. | 이순영 |
| 2022 | | Does severe subacute noise exposure increase risk of new onset hypertension beyond conventional risk factors? A 30 000 person-years cohort study | 정인철 |
| 2023 | | E/e’ Ratio Predicts the Atrial Pacing-Induced Left Atrial Pressure Response in Patients with Preserved Ejection Fraction | 이광노 |
| 2015 | | Effect of hypertension on the resting-state functional connectivity in patients with Alzheimer's disease (AD). | 손상준, 홍창형 |
| 2024 | | Effect of motivated physicians and elderly patients with hypertension or type 2 diabetes mellitus in prepared communities on health behaviours and outcomes: A population-based PS matched retrospective cohort study during five-year follow-up period | 이순영 |
| 2016 | | Effects of an empowerment program for self-management among rural older adults with hypertension in South Korea | 김춘자 |
| 2017 | | Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study | 김대중, 김혜진, 이관우, 한승진 |
| 2020 | | Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia | 최소연 |
| 2016 | | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) | 박진선, 신준한 |
| 2022 | | Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial | 신준한 |
| 2020 | | Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia | 신준한 |
| 2023 | | Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial | 최소연 |
| 2016 | | Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial | 신준한 |
| 2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
| 2019 | | Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study | 윤명호 |
| 2015 | | Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy. | 신준한 |
| 2015 | | Elevated serum ferritin and mercury concentrations are associated with hypertension; analysis of the fourth and fifth Korea national health and nutrition examination survey (KNHANES IV-2, 3, 2008-2009 and V-1, 2010) | 김규남, 주남석 |
| 2003 | | Endothelial dysfunction and alteration of nitric oxide/ cyclic GMP pathway in patients with exercise-induced hypertension. | 신준한, 윤명호, 장혁재, 최병일, 최병주, 최소연, 최태영, 탁승제, 황교승 |
| 2004 | | Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test. | 신준한, 윤명호, 최소연, 탁승제, 황교승 |
| 2018 | | Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis | 부선주 |
| 2015 | | Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial. | 신준한 |
| 2022 | | Factors associated with motor severity in vascular parkinsonism with normal dopamine transporter imaging | 박동규, 윤정한 |
| 2016 | | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension | 강대용 |
| 2010 | | Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and/or hypertension in two Korean cohorts. | 진현석 |
| 2014 | | Health-Related Quality of Life and Associated Factors in Patients with Hypertension | 최미니 |
| 2013 | | Healthy range of serum alanine aminotransferase and its predictive power for cardiovascular risk in children and adolescents. | 황진순 |
| 2015 | | High Blood Pressure and Its Association With Incident Diabetes Over 10 Years in the Korean Genome and Epidemiology Study (KoGES). | 조남한 |
| 2014 | | Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011 | 김대중 |
| 2019 | | Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine gamma-lyase protein degradation | 변혜은, 이상윤 |
| 2020 | | Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine gamma-lyase degradation | 이상윤, 이숙영 |
